Evidence mapPaperPMID 31901784Full record

ArticleAutonomic neuroscience : basic & clinical2020

Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: A novel fluorescence imaging method.

Lily L Cao, Andrew P Holmes, Janice M Marshall, Larissa Fabritz, Keith L Brain

Open access · hybridAbstract read
In one paragraph

Article in Autonomic neuroscience : basic & clinical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lily L CaoSchool of Biomedical Science, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom. Electronic address: LXC319@student.bham.ac.uk.
Andrew P HolmesSchool of Biomedical Science, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom. Electronic address: A.P.Holmes@bham.ac.uk.
Janice M MarshallSchool of Biomedical Science, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom. Electronic address: j.m.marshall@bham.ac.uk.
Larissa FabritzInstitute of Cardiovascular Science, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Electronic address: L.Fabritz@bham.ac.uk.
Keith L BrainSchool of Biomedical Science, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom. Electronic address: k.l.brain@bham.ac.uk.
University of Birmingham · GB

Funding

British Heart Foundation FS/17/7/32651
6 · The paper itself

Abstract

Here, we validate the use of a novel fluorescent norepinephrine transporter (NET) substrate for dynamic measurements of transporter function in rodent cardiovascular tissue; this technique avoids the use of radiotracers and provides single-terminal resolution. Rodent (Wistar rats and C57BL/6 mice) hearts and mesenteric arteries (MA) were isolated, loaded with NET substrate Neurotransmitter Transporter Uptake Assay (NTUA) ex vivo and imaged with confocal microscopy. NTUA labelled noradrenergic nerve terminals in all four chambers of the heart and on the surface of MA. In all tissues, a temperature-dependent, stable linear increase in intra-terminal fluorescence upon NTUA exposure was observed; this was abolished by NET inhibitor desipramine (1 μM) and reversed by indirectly-acting sympathomimetic amine tyramine (10 μM). NET reuptake rates were similar across the mouse cardiac chambers. In both species, cardiac NET activity was significantly greater than in MA (by 62 ± 29% (mouse) and 21 ± 16% (rat)). We also show that mouse NET reuptake rate was twice as fast as that in the rat (for example, in the heart, by 94 ± 30%). Finally, NET reuptake rate in the mouse heart was attenuated with muscarinic agonist carbachol (10 μM) thus demonstrating the potential for parasympathetic regulation of norepinephrine clearance. Our data provide the first demonstration of monitoring intra-terminal NET function in rodent cardiovascular tissue. This straightforward method allows dynamic measurements of transporter rate in response to varying physiological conditions and drug treatments; this offers the potential to study new mechanisms of sympathetic dysfunction associated with cardiovascular disease.

Indexed as

Fluorescent DyesAdrenergic Uptake InhibitorsAnimalsCarbacholCholinergic AgonistsDesipramineDiagnostic ImagingFemaleHeartMaleMesenteric ArteriesMiceMice, Inbred C57BLMicroscopy, ConfocalNorepinephrine Plasma Membrane Transport ProteinsRatsAdrenergic Uptake InhibitorsCarbacholCholinergic AgonistsDesipramineFluorescent DyesNorepinephrine Plasma Membrane Transport ProteinsCardiovascular systemFluorescence imagingNorepinephrine transporter kineticsRodentSympathetic

Identifiers

PMID31901784
PMCPMC6977090
OpenAlexW2997586206

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.